Crossmark

Quantifying endosomal escape in vivo to guide lipid nanoparticle design

Crossref DOI link: https://doi.org/10.1038/s41587-026-03047-x

Published Online: 2026-03-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Zhengwei https://orcid.org/0009-0003-5105-6709
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
License Information

Text and Data Mining valid from 2026-03-11

Version of Record valid from 2026-03-11
More Information

Article History

First Online: 11 March 2026

Competing interests

: Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics.